Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Levilimab (Anti-IL-6Ra / CD126) For research use only.
Not for use in humans.

Levilimab (Anti-IL-6Ra / CD126)

Synonyms: BCD-089

Levilimab (Anti-IL-6Ra / CD126) is a fully human monoclonal antibody targeting interleukin-6 receptor (IL-6R). It is an inflammation-alleviating antibody and can be used for the research of rheumatoid arthritis and covid-19 treatment. MW :145.62 KD.

Levilimab (Anti-IL-6Ra / CD126)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Levilimab (Anti-IL-6Ra / CD126) is a fully human monoclonal antibody targeting interleukin-6 receptor (IL-6R). It is an inflammation-alleviating antibody and can be used for the research of rheumatoid arthritis and covid-19 treatment. MW :145.62 KD.

Product Details

CAS No. 2035008-70-7
Molecular Weight 145.62
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Levilimab (Anti-IL-6Ra / CD126) | Levilimab (Anti-IL-6Ra / CD126) supplier | purchase Levilimab (Anti-IL-6Ra / CD126) | Levilimab (Anti-IL-6Ra / CD126) cost | Levilimab (Anti-IL-6Ra / CD126) manufacturer | order Levilimab (Anti-IL-6Ra / CD126) | Levilimab (Anti-IL-6Ra / CD126) distributor